| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.32 | 1e-12 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.22 | 9e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.27 | 1e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.22 | 5e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.33 | 7e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.27 | 1e-06 |